J Breneman
Overview
Explore the profile of J Breneman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joshi D, Anderson J, Paidas C, Breneman J, Parham D, Crist W
Pediatr Blood Cancer
. 2004 Jan;
42(1):64-73.
PMID: 14752797
Background: Although age <1 year at diagnosis has been associated with a worse prognosis in rhabdomyosarcoma (RMS), the relationship of age at diagnosis to clinical presentation and outcome has not...
2.
Crist W, ANDERSON J, Meza J, Fryer C, RANEY R, RUYMANN F, et al.
J Clin Oncol
. 2001 Jun;
19(12):3091-102.
PMID: 11408506
Purpose: The study goal was to improve outcome in children with rhabdomyosarcoma by comparing risk-based regimens of surgery, radiotherapy (RT) and chemotherapy. Patients And Methods: Eight hundred eighty-three previously untreated...
3.
Pappo A, Lyden E, Breneman J, Wiener E, Teot L, Meza J, et al.
J Clin Oncol
. 2001 Jan;
19(1):213-9.
PMID: 11134215
Purpose: To investigate the antitumor activity and toxicity of topotecan, used alone and in combination with conventional therapy, in patients with metastatic rhabdomyosarcoma (RMS). Patients And Methods: Forty-eight patients younger...
4.
Moyer P, Golnik K, Breneman J
Am J Ophthalmol
. 2000 Jun;
129(5):694-6.
PMID: 10844079
Purpose: To report a patient recovering vision after three-dimensional conformal radiotherapy for optic nerve sheath meningioma. Methods: Radiotherapy was delivered by a three-dimensional conformal technique in 28-180-cGy fractions. Results: Visual...
5.
Wharam M, Hanfelt J, Tefft M, Johnston J, Ensign L, Breneman J, et al.
Int J Radiat Oncol Biol Phys
. 1997 Jul;
38(4):797-804.
PMID: 9240649
Purpose: A subset of 362 pediatric patients with rhabdomyosarcoma was selected from a total of 532 eligible IRS-II patients in Clinical Group III to assess the local and regional failure...
6.
Arndt C, Tefft M, GEHAN E, Anderson J, Jenson M, Link M, et al.
J Pediatr Hematol Oncol
. 1997 Mar;
19(2):124-9.
PMID: 9149741
Purpose: The purpose of this study was to determine the feasibility, toxicity, and early response of patients with clinical group III rhabdomyosarcoma (RMS) to a chemotherapy regimen of etoposide (ETOP),...
7.
Lowe X, Collins B, Allen J, Breneman J, van Beek M, Bishop J, et al.
Mutat Res
. 1995 Oct;
338(1-6):59-76.
PMID: 7565883
The objective of this research was to determine whether the frequencies of chromosomally defective germ cells increased with age in male laboratory mice. Two types of chromosomal abnormalities were characterized:...
8.
Donaldson S, Asmar L, Breneman J, Fryer C, GLICKSMAN A, Laurie F, et al.
Int J Radiat Oncol Biol Phys
. 1995 Jul;
32(4):903-11.
PMID: 7607964
Purpose: The Intergroup Rhabdomyosarcoma Study (IRS) Group initiated a pilot study (IRS IV-P) of hyperfractionated radiation (HF XRT) with chemotherapy to test the feasibility and toxicity of this combined modality...
9.
Breneman J, Breneman D
Int J Radiat Oncol Biol Phys
. 1995 Apr;
32(1):274.
PMID: 7721632
No abstract available.